Page last updated: 2024-11-07

pentolinium tartrate and Parkinsonian Disorders

pentolinium tartrate has been researched along with Parkinsonian Disorders in 1 studies

Pentolinium Tartrate: A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension.
pentolinium tartrate : The bitartrate salt of pentolinium.

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
PEASTON, MJ1

Other Studies

1 other study available for pentolinium tartrate and Parkinsonian Disorders

ArticleYear
PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.
    British medical journal, 1964, Jul-18, Volume: 2, Issue:5402

    Topics: Antihypertensive Agents; Brain Diseases; Humans; Methyldopa; Parkinsonian Disorders; Pempidine; Pent

1964